Biomedica GMBH

Biomedica is a pharmaceutical company specialised in the commercialisation of rare disease products for patients in underserved emerging markets. We focus on rare diseases, with a rapidly expanding portfolio of TAs, and possess strong specialization and professional capabilities in orphan drug pathways. In an interconnected world, the boundaries of healthcare equity should not be defined by geography or economic status. As a leading pharmaceutical company, you have the power and responsibility to redefine global health paradigms. Access to essential medicines is a fundamental human right, and every individual, from bustling metropolises to the most remote corners of emerging nations, deserves...

Pharmaceutical market access,drug distribution,emerging market's access,ethical and compliant market access,cis,cee,gcc,mena,latam,named patient program,rare decease drugs distribution,registered and unregistered medicine ,and market access for unregistered medicine in emerging markets

Biomedica gmbh operates in the Pharmaceutical manufacturing industry.

Biomedica gmbh's revenue is 11m - 100m

Biomedica gmbh has 11 - 50 employees.